DocMorris AG is a European digital health and e-commerce pharmacy company headquartered in Frauenfeld, Switzerland. The company operates a direct-to-consumer business model, generating revenue primarily through the online retail of prescription (Rx) and over-the-counter (OTC) medications, alongside consumer health, beauty, and personal care products. Geographically, the company's operations are heavily concentrated in Germany, which accounted for approximately 94% of its CHF 1.12 billion revenue in 2024, with the remainder generated from its Europe segment, including operations in Spain and France.
DocMorris fulfills its orders primarily from an automated logistics center in Heerlen, the Netherlands, which serves the German market. In addition to its core retail pharmacy business, the company has expanded into digital health services. This includes TeleClinic, a telemedicine platform that connects patients with doctors for video consultations and electronic prescriptions. The company also operates health and personal care marketplaces in Southern Europe under the PromoFarma and DoctiPharma brands.
Following the divestment of its Swiss wholesale and retail operations in 2023, the company rebranded from Zur Rose Group AG to DocMorris AG to reflect its focus on its primary consumer brand. The company's competitive position is supported by its active customer base of over 10 million users and its positioning to participate in the ongoing rollout of electronic prescriptions (eRx) in the German healthcare system.
